230 related articles for article (PubMed ID: 11524770)
21. [Principles of treatment of hemoblastoses under ambulatory conditions].
Polonskaia EN; Vinogradova IuE; Lobanova NA; Iudina NI; Korovina VI
Ter Arkh; 1976; 48(8):54-60. PubMed ID: 828780
[No Abstract] [Full Text] [Related]
22. [Interferon and hairy cell leukemia].
Castaigne S; Floch M; Montaron B
Soins; 1986 Aug; (483-484):9-10, 12. PubMed ID: 2430339
[No Abstract] [Full Text] [Related]
23. Interferon induced severe digital ischaemia in chronic myeloid leukaemia--successful treatment using ketanserin.
Sachithanandan A; Cuthbert RJ; Barros d'Sa AA
Eur J Vasc Endovasc Surg; 2001 Nov; 22(5):474-6. PubMed ID: 11735190
[No Abstract] [Full Text] [Related]
24. [Chronic myeloid leukemia as a model for the development and therapeutic use of tyrosine kinase inhibitors].
López-Karpovitch X
Rev Invest Clin; 2003; 55(2):191-5. PubMed ID: 12827926
[No Abstract] [Full Text] [Related]
25. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
[TBL] [Abstract][Full Text] [Related]
26. 2-Chlorodeoxyadenosine: a new nucleoside agent effective in the treatment of lymphoid malignancies.
Saven A; Piro LD
Leuk Lymphoma; 1993; 10 Suppl():43-9. PubMed ID: 8097654
[No Abstract] [Full Text] [Related]
27. [Cytochemical stains of value in hematological diagnosis].
Lagerlöf B; Sundström C; Ost A
Lakartidningen; 1979 Dec; 76(49):4495-8. PubMed ID: 94646
[No Abstract] [Full Text] [Related]
28. Into interferon.
Salaman JR
Eur J Surg Oncol; 1994 Jun; 20(3):251-2. PubMed ID: 7514142
[No Abstract] [Full Text] [Related]
29. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
30. A summer of hematologic science. Highlights from the 45th Annual Meeting of the American Society of Clinical Oncology, the 14th Congress of the European Hematology Association, and the 2009 Pan Pacific Lymphoma Conference.
Cheson BD; Ashforth E
Clin Adv Hematol Oncol; 2009 Sep; 7(9 Suppl 15):1-22; quiz 23-4. PubMed ID: 20102012
[No Abstract] [Full Text] [Related]
31. JAK2 inhibitors: not the next imatinib but researchers see other possibilities.
Garber K
J Natl Cancer Inst; 2009 Jul; 101(14):980-2. PubMed ID: 19584324
[No Abstract] [Full Text] [Related]
32. Present status and future problems of interferon in the treatment of hematological malignancies.
Kimura K
Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1677-87. PubMed ID: 2425532
[No Abstract] [Full Text] [Related]
33. Endometrial extramedullary haemopoiesis.
Creagh TM; Bain BJ; Evans DJ; Reid CD; Young RH; Flanagan AM
J Pathol; 1995 May; 176(1):99-104. PubMed ID: 7616362
[TBL] [Abstract][Full Text] [Related]
34. 2nd International Congress on Leukemia, Lymphoma and Myeloma.
Arat M; Ozsan GH; Yenerel MN; Cetin M; Ozcan M
Expert Rev Hematol; 2009 Oct; 2(5):509-12. PubMed ID: 21083016
[TBL] [Abstract][Full Text] [Related]
35. [Androgens in hematology].
Sanchez-Medal L
Minerva Med; 1971 Jun; 62(51):2598-604. PubMed ID: 5566873
[No Abstract] [Full Text] [Related]
36. Development and mechanisms of interferon resistance.
Kloke O; Niederle N
Cancer Treat Rev; 1990 Dec; 17 Suppl A():81-8. PubMed ID: 1709389
[No Abstract] [Full Text] [Related]
37. Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?
Cashen A; DiPersio JF; Khoury H
J Clin Oncol; 2003 Nov; 21(22):4255-6. PubMed ID: 14615462
[No Abstract] [Full Text] [Related]
38. Recent advancements in the treatment of chronic myelogenous leukemia.
O'Dwyer ME; Mauro MJ; Druker BJ
Annu Rev Med; 2002; 53():369-81. PubMed ID: 11818480
[TBL] [Abstract][Full Text] [Related]
39. [Optimising therapy in patients with haematological malignancies].
Dumontet C
Bull Cancer; 2008 Oct; 95(10):959-62. PubMed ID: 19004726
[TBL] [Abstract][Full Text] [Related]
40. Chronic myeloid leukemia.
Singhal N; Bapsy PP; Babu KG; George J
J Assoc Physicians India; 2004 May; 52():410-6. PubMed ID: 15656033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
